Explore the Potential with AI-Driven Innovation
This comprehensive focused library is produced on demand with state-of-the-art virtual screening and parameter assessment technology driven by Receptor.AI drug discovery platform. This approach outperforms traditional methods and provides higher-quality compounds with superior activity, selectivity and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
We use our state-of-the-art dedicated workflow for designing focused libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
The method includes detailed molecular simulations of the catalytic and allosteric binding pockets, along with ensemble virtual screening that considers their conformational flexibility. In the design of modulators, structural changes induced by reaction intermediates are taken into account to enhance activity and selectivity.
Key features that set our library apart include:
partner
Reaxense
upacc
Q12891
UPID:
HYAL2_HUMAN
Alternative names:
Hyaluronoglucosaminidase-2; Lung carcinoma protein 2
Alternative UPACC:
Q12891; B3KRZ2; O15177; Q9BW29
Background:
Hyaluronidase-2, also known as Hyaluronoglucosaminidase-2 or Lung carcinoma protein 2, plays a crucial role in the hydrolysis of high molecular weight hyaluronic acid. This process produces intermediate-sized products, which are further broken down into small oligosaccharides by sperm hyaluronidase. Despite its low activity levels, Hyaluronidase-2 is significant for its association with and regulation of MST1R.
Therapeutic significance:
Understanding the role of Hyaluronidase-2 could open doors to potential therapeutic strategies. Its involvement in the breakdown of hyaluronic acid and regulation of MST1R highlights its potential as a target in therapeutic interventions.